Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

Source:http://linkedlifedata.com/resource/pubmed/id/8213583

Am. J. Cardiol. 1993 Nov 1 72 14 1031-7

Download in:

View as

General Info

PMID
8213583